Publications by authors named "Bishun Deng"

Background: T follicular helper (Tfh) cells drive humoral immunity by facilitating B cell responses, but the functional role of Tfh cells in the pathogenesis of idiopathic membranous nephropathy (IMN) remains unclear.

Objectives: This study aimed to establish a rat experimental membranous nephropathy model, investigate the phenotypic characteristics of Tfh cells, and analyze a clinically significant correlation between Tfh cells.

Material And Methods: Passive Heymann nephritis (PHN) rats were induced by immunizing Sprague Dawley rats with anti-Fx1A serum.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of T follicular helper (Tfh) cells and their subsets in idiopathic membranous nephropathy (IMN).
  • It finds that patients with IMN have higher frequencies of specific Tfh cells and that these cells have distinct characteristics compared to those in healthy controls.
  • The research highlights that Tfh cells can promote B cell differentiation, notably influenced by IL-21, suggesting that monitoring Tfh2 cells could help assess IMN progression.
View Article and Find Full Text PDF

Triptolide (TPT) is widely used in the treatment of rheumatoid arthritis (RA). However, its regulatory mechanisms are not fully understood. This study demonstrated that Myeloid-derived suppressor cells (MDSCs) were expanded in both RA patients and arthritic mice.

View Article and Find Full Text PDF

CD19CD24CD38 regulatory B cells exert immunosuppressive functions by producing IL-10, but their role in idiopathic membranous nephropathy (IMN) remains elusive. Here, we investigated the frequency and functional changes of circulating CD19CD24CD38 B cells and evaluated the correlation of CD19CD24CD38 B cells with clinical features and T helper cell subsets in IMN patients. Compared with healthy controls (HCs), IMN patients showed an increased frequency of CD19CD24CD38 B cells, but a significant reduction in the percentage of CD19CD24CD38 B cells was observed 4 weeks after cyclophosphamide treatment.

View Article and Find Full Text PDF